Article Details

U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a ...

Retrieved on: 2021-10-04 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a .... View article details on hiswai:

Excerpt

4, 2021 /PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders today ...

Article found on: www.wbay.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up